• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级卵巢癌手术质量:ESGO 质量指标的法国评估。

Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators.

机构信息

Department of Surgical Oncology, Institut Cancérologie de L'Ouest, Nantes, Saint Herblain, France.

Department of Surgical Oncology, Institut Cancérologie de L'Ouest, Nantes, Saint Herblain, France.

出版信息

Eur J Surg Oncol. 2021 Feb;47(2):360-366. doi: 10.1016/j.ejso.2020.08.003. Epub 2020 Aug 11.

DOI:10.1016/j.ejso.2020.08.003
PMID:32863097
Abstract

OBJECTIVES

In 2016, the European Society of Gynecology Oncology (ESGO) published indicators defining the quality of surgical management of advanced ovarian cancer. The objective of the study was to assess the quality of ovarian cancer patient management in regional centers authorized for gynecological cancer, based on the ESGO list of quality indicators.

METHODS

A multicenter retrospective observational cohort study was conducted from January 1 to June 30, 2016. The following quality indicators 1 "rate of complete surgical resection", 4 "center participating in clinical trials in gynecologic oncology", 5 "treatment planned and reviewed at a multidisciplinary team meeting", 6 "required preoperative workup", 8 "minimum required elements in operative reports" and 9 "minimum required elements in pathology reports" were selected.

RESULTS

91 patients were evaluated in 16 centers. The required preoperative workup was incomplete in 25% of cases. Treatment was not planned at a multidisciplinary team meeting for 24%. An evaluation score of peritoneal involvement was included in 40% of the operative reports and the quality of surgical resection was reported in 72%. Primary surgery was most often performed in a peripheral hospital (48%), interval surgery in a private center (37%), and closure surgery in a regional cancer center (43%). No institution respected the six quality indicators evaluated. One regional cancer center respected five items and two private centers did not respect any.

CONCLUSION

Whilst the ESGO quality indicators provide objective, validated and evaluable support which centers can use to improve quality of care, we observed heterogeneous practices amongst the centers evaluated.

摘要

目的

2016 年,欧洲妇科肿瘤学会(ESGO)发布了定义高级卵巢癌手术管理质量的指标。本研究的目的是根据 ESGO 质量指标清单,评估获得妇科癌症授权的区域中心对卵巢癌患者管理的质量。

方法

这是一项多中心回顾性观察队列研究,于 2016 年 1 月 1 日至 6 月 30 日进行。选择了以下质量指标 1“完全手术切除率”、4“参与妇科肿瘤临床试验的中心”、5“在多学科团队会议上计划和审查治疗方案”、6“需要术前检查”、8“手术报告中必需的最低要素”和 9“病理报告中必需的最低要素”。

结果

在 16 个中心评估了 91 名患者。25%的病例术前检查不完整,24%的病例未在多学科团队会议上计划治疗方案。40%的手术报告中包含腹膜侵犯评估评分,72%的报告中报告了手术切除质量。初次手术大多在周边医院(48%)进行,间隔手术在私立中心(37%)进行,关闭手术在区域癌症中心(43%)进行。没有一个机构符合所评估的 6 个质量指标。一个区域癌症中心符合五项指标,两个私立中心没有符合任何一项。

结论

尽管 ESGO 质量指标提供了客观、经过验证和可评估的支持,中心可以利用这些支持来提高护理质量,但我们观察到评估中心之间的实践存在差异。

相似文献

1
Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators.高级卵巢癌手术质量:ESGO 质量指标的法国评估。
Eur J Surg Oncol. 2021 Feb;47(2):360-366. doi: 10.1016/j.ejso.2020.08.003. Epub 2020 Aug 11.
2
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.欧洲妇科肿瘤学会晚期卵巢癌手术质量指标
Int J Gynecol Cancer. 2016 Sep;26(7):1354-63. doi: 10.1097/IGC.0000000000000767.
3
Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update.欧洲妇科肿瘤学会(ESGO)晚期卵巢癌手术质量指标:2020年更新
Int J Gynecol Cancer. 2020 Apr;30(4):436-440. doi: 10.1136/ijgc-2020-001248. Epub 2020 Feb 20.
4
Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).卵巢癌手术中的质量指标:法国妇科肿瘤学会(Societe Francaise d'Oncologie Gynecologique,SFOG)报告。
Ann Oncol. 2013 Nov;24(11):2732-9. doi: 10.1093/annonc/mdt237. Epub 2013 Jul 14.
5
Centralizing surgery for ovarian cancer in a 'non-centralizing' country (Belgium): the UNGO (UCLouvain Network of Gynaecological Oncology) experience.在一个“非集中化”的国家(比利时)集中进行卵巢癌手术:UNGO(鲁汶大学妇科肿瘤学网络)的经验。
Int J Gynecol Cancer. 2024 Jan 5;34(1):106-112. doi: 10.1136/ijgc-2023-004401.
6
Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).遵循欧洲卵巢癌指南与生存获益:一项法国多中心研究(FRANCOGYN)。
Int J Gynecol Cancer. 2021 Nov;31(11):1443-1452. doi: 10.1136/ijgc-2021-002934. Epub 2021 Oct 4.
7
Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study.卵巢癌手术中对法国和欧洲妇科肿瘤学会质量指标的遵循情况:来自前瞻性多中心CURSOC研究的专项分析
Cancers (Basel). 2021 Mar 30;13(7):1593. doi: 10.3390/cancers13071593.
8
Ovarian cancer management in an ESGO ovarian cancer center of excellence: a systematic case study of the interprofessional and interdisciplinary interaction.ESGO 卓越卵巢癌中心的卵巢癌管理:跨专业和跨学科互动的系统案例研究。
Arch Gynecol Obstet. 2024 Jun;309(6):2821-2828. doi: 10.1007/s00404-023-07368-z. Epub 2024 Mar 20.
9
Current clinical practice in cytoreductive surgery for advanced ovarian cancer: a European survey.当前晚期卵巢癌细胞减灭术的临床实践:一项欧洲调查。
Int J Gynecol Cancer. 2011 Oct;21(7):1219-24. doi: 10.1097/IGC.0b013e318227c971.
10
Assessment of ESGO Quality Indicators in Cervical Cancer Surgery: A Real-World Study in a High-Volume Chinese Hospital.子宫颈癌手术中欧洲妇科肿瘤学会质量指标的评估:在中国一家高容量医院开展的一项真实世界研究
Front Oncol. 2022 Jan 25;12:802433. doi: 10.3389/fonc.2022.802433. eCollection 2022.

引用本文的文献

1
Impact of Ovarian Cancer Surgery Volume on Overall and Progression-Free Survival: A Population-Based Retrospective National French Study.卵巢癌手术量对总生存和无进展生存的影响:一项基于人群的法国全国回顾性研究。
Ann Surg Oncol. 2024 May;31(5):3269-3279. doi: 10.1245/s10434-024-15050-0. Epub 2024 Feb 23.
2
A scoping review on population-centered indicators for cancer care continuum.以人群为中心的癌症照护连续体指标的范围综述。
Front Public Health. 2022 Oct 14;10:912946. doi: 10.3389/fpubh.2022.912946. eCollection 2022.
3
Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups.
评估高级卵巢(输卵管/腹膜)癌患者的围手术期管理:MITO-MaNGO 组的一项调查。
J Gynecol Oncol. 2022 Sep;33(5):e60. doi: 10.3802/jgo.2022.33.e60. Epub 2022 Jun 3.
4
Assessment of ESGO Quality Indicators in Cervical Cancer Surgery: A Real-World Study in a High-Volume Chinese Hospital.子宫颈癌手术中欧洲妇科肿瘤学会质量指标的评估:在中国一家高容量医院开展的一项真实世界研究
Front Oncol. 2022 Jan 25;12:802433. doi: 10.3389/fonc.2022.802433. eCollection 2022.
5
Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer.2021年法国晚期上皮性卵巢癌患者管理全国性调查结果。
J Clin Med. 2021 Oct 21;10(21):4829. doi: 10.3390/jcm10214829.
6
Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study.卵巢癌手术中对法国和欧洲妇科肿瘤学会质量指标的遵循情况:来自前瞻性多中心CURSOC研究的专项分析
Cancers (Basel). 2021 Mar 30;13(7):1593. doi: 10.3390/cancers13071593.